Hydroxy(oxo)methanesulfonic acid (BioDeep_00000174609)

   

human metabolite blood metabolite


代谢物信息卡片


Hydroxy(oxo)methanesulphonic acid

化学式: CH2O5S (125.9622962)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 99.31%

分子结构信息

SMILES: C(=O)(O)S(=O)(=O)O
InChI: InChI=1S/CH2O5S/c2-1(3)7(4,5)6/h(H,2,3)(H,4,5,6)



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Lidia Dalfino, Filomena Puntillo, Adriana Mosca, Rosa Monno, Maria Luigia Spada, Sara Coppolecchia, Giuseppe Miragliotta, Francesco Bruno, Nicola Brienza. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Jun; 54(12):1720-6. doi: 10.1093/cid/cis286. [PMID: 22423120]
  • Ana Carolina Ariza, Peter Meinardus T Deen, Joris Hubertus Robben. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Frontiers in endocrinology. 2012; 3(?):22. doi: 10.3389/fendo.2012.00022. [PMID: 22649411]
  • Stewart Frankel, Blanka Rogina. Indy mutants: live long and prosper. Frontiers in genetics. 2012; 3(?):13. doi: 10.3389/fgene.2012.00013. [PMID: 22363340]
  • Hideki Takahashi, Peter Buchner, Naoko Yoshimoto, Malcolm J Hawkesford, Shin-Han Shiu. Evolutionary relationships and functional diversity of plant sulfate transporters. Frontiers in plant science. 2011; 2(?):119. doi: 10.3389/fpls.2011.00119. [PMID: 22629272]
  • Roger L Chang, Li Xie, Lei Xie, Philip E Bourne, Bernhard Ø Palsson. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS computational biology. 2010 Sep; 6(9):e1000938. doi: 10.1371/journal.pcbi.1000938. [PMID: 20957118]
  • Vicente Pintado, Lucía García San Miguel, Fabio Grill, Blanca Mejía, Javier Cobo, Jesús Fortún, Pilar Martín-Dávila, Santiago Moreno. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. The Journal of infection. 2008 Mar; 56(3):185-90. doi: 10.1016/j.jinf.2008.01.003. [PMID: 18280570]
  • E M Westerman, A H De Boer, P P H Le Brun, D J Touw, A C Roldaan, H W Frijlink, H G M Heijerman. Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2007 Jul; 6(4):284-92. doi: 10.1016/j.jcf.2006.10.010. [PMID: 17185047]
  • M Wootton, H A Holt, A P Macgowan. Development of a novel assay method for colistin sulphomethate. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2005 Mar; 11(3):243-4. doi: 10.1111/j.1469-0691.2005.01076.x. [PMID: 15715726]
  • Samira Mubareka, Ethan Rubinstein. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Critical care (London, England). 2005 Feb; 9(1):29-30. doi: 10.1186/cc3036. [PMID: 15693979]
  • Matthew E Falagas, Michael Rizos, Ioannis A Bliziotis, Kostas Rellos, Sofia K Kasiakou, Argyris Michalopoulos. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC infectious diseases. 2005 Jan; 5(?):1. doi: 10.1186/1471-2334-5-1. [PMID: 15642116]
  • M Al-Aloul, H Miller, S Alapati, P A Stockton, M J Ledson, M J Walshaw. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatric pulmonology. 2005 Jan; 39(1):15-20. doi: 10.1002/ppul.20138. [PMID: 15521084]
  • Andreina Poggi, Cosmo Rossi, Nicola Casella, Cristiana Bruno, Luisella Sturiale, Carla Dossi, Annamaria Naggi. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide. Seminars in thrombosis and hemostasis. 2002 Aug; 28(4):383-92. doi: 10.1055/s-2002-34308. [PMID: 12244486]
  • P P H Le Brun, A H de Boer, G P M Mannes, D M I de Fraîture, R W Brimicombe, D J Touw, A A Vinks, H W Frijlink, H G M Heijerman. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2002 Jul; 54(1):25-32. doi: 10.1016/s0939-6411(02)00044-9. [PMID: 12084499]
  • M E Jiménez-Mejías, C Pichardo-Guerrero, F J Márquez-Rivas, D Martín-Lozano, T Prados, J Pachón. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2002 Mar; 21(3):212-4. doi: 10.1007/s10096-001-0680-2. [PMID: 11957024]